Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex & ORCID
How has Javier Gómez‐Román's publication output changed over time?
ScholarIQpublication output · 1997–2024
Output grew0% over the shown period — from 1 works in 1997 to 1 in 2024.
1
1
2
1
3
2
1
1997200320052009201420192024
What are the most-cited papers on Javier Gómez‐Román?
ScholarIQmost cited works
Efficacy and Safety of Trabectedin in Patients With Advanced or Metastatic Liposarcoma or Leiomyosarcoma After Failure of Prior Anthracyclines and Ifosfamide: Results of a Randomized Phase II Study of Two Different Schedules
George D. Demetri, Sant P. Chawla, Margaret von Mehren, Paul S. Ritch, Laurence H. Baker, Jean‐Yves Blay, Kenneth R. Hande, Mary Lou Keohan, Brian L. Samuels, Scott M. Schuetze, Claudia Lebedinsky, Yusri Elsayed, Miguel Izquierdo, Javier Gómez‐Román, Youn C. Park, Axel Le Cesne
Journal of Clinical Oncology. 2009537 CitationsOPEN ACCESS
Reduced <i>NF1</i> Expression Confers Resistance to EGFR Inhibition in Lung Cancer
Elza C. de Bruin, Catherine Cowell, Patricia H. Warne, Ming Jiang, Rebecca E. Saunders, Mary Ann Melnick, Scott Gettinger, Zenta Walther, Anna Wurtz, Guus J.J.E. Heynen, Daniëlle A.M. Heideman, Javier Gómez‐Román, Almudena García‐Castaño, Yixuan Gong, Marc Ladanyi, Harold Varmus, René Bernards, Egbert F. Smit, Katerina Politi, Julian Downward
Cancer Discovery. 2014210 CitationsOPEN ACCESS
Clinicopathologic Study and DNA Analysis of 37 Cardiac Myxomas
Elvira Acebo, J. Fernando Val‐Bernal, Javier Gómez‐Román, José M. Revuelta
CHEST Journal. 2003129 Citations
Fibroblast Growth Factor Receptor 3 Is Overexpressed in Urinary Tract Carcinomas and Modulates the Neoplastic Cell Growth
Javier Gómez‐Román, Pilar Sáenz, Jorge Cuevas González, Kepa Escuredo, Simon Santa Cruz, Corina Junquera, Laureano Simón, Antonio Martı́nez, J.L. Gutiérrez Baños, M. López-Brea, C. Esparza, J. Fernando Val‐Bernal
Clinical Cancer Research. 2005117 CitationsOPEN ACCESS
Updated guidelines for predictive biomarker testing in advanced non-small-cell lung cancer: a National Consensus of the Spanish Society of Pathology and the Spanish Society of Medical Oncology
Pilar Garrido, Esther Conde, J. de Castro, Javier Gómez‐Román, Enriqueta Felip, Lara Pijuán, Dolores Isla, J. Sanz, Luis Paz‐Ares, Fernando López‐Ríos
S179824187. 2019106 CitationsOPEN ACCESS
Related on ScholarIQ
Universidad de Cantabria
Institution
Efficacy and Safety of Trabectedin in Patients With Advanced or Metastatic Liposarcoma or Leiomyosarcoma After Failure of Prior Anthracyclines and Ifosfamide: Results of a Randomized Phase II Study of Two Different Schedules
Paper
Reduced <i>NF1</i> Expression Confers Resistance to EGFR Inhibition in Lung Cancer
Paper
Clinicopathologic Study and DNA Analysis of 37 Cardiac Myxomas
Paper
Fibroblast Growth Factor Receptor 3 Is Overexpressed in Urinary Tract Carcinomas and Modulates the Neoplastic Cell Growth
Paper
Updated guidelines for predictive biomarker testing in advanced non-small-cell lung cancer: a National Consensus of the Spanish Society of Pathology and the Spanish Society of Medical Oncology
Paper